Mon 6/18/2018 21:15 ET
S&P 5002773.875.830.21%BANKS468.790.840.18%OIL65.480.210.32%BITCOIN6720.225.380.08%
Welcome Stranger!  Please sign up or log in to enable additional features.Sign Up | Mail | Log In
Forum - Dyax - DYAX   

Msg Top | Msg List | < Prev | Next > | Post New | Reply | Privately | Search | Add DYAX
From: hazeleye (Rep: 257) reply to hazeleyeDate: 02/21/2013 12:37
Forum: Dyax - Msg #480Thread #673378386 (Rec: 0)
Re: Institutional Ownership up to WHOPPING 78% /// Now up to 80%...

I suppose we'll actually start seeing some large brokerage commencing coverage soon enough ... with glowing reports of course. With 80% IO, only a matter of time IMO.

meep meep buy dyax meep meep

Reply to hazeleye - Msg #475 - 12/11/2012 12:37

NEW *31 MONTH* HIGH ! Institutional Ownership up to WHOPPING 78% and more...

Here are some more institutional ownership comparisons:
Bacterin International... 13%
Zinga... 35%
Facebook... 36%
Ford... 52%
Dendreon... 59%
Johnson and Johnson... 64%
Apple... 65%
Amazon... 67%
Eli Lilly... 73% (Dyax Partner)
Dyax... 78%
Biogen... 90% (Dyax Parnter)

Name me another stock that has was trading in the $1.50 range within the past 12 month who has institutional ownership this high. HEAVY stealth accumulation has been going on in DYAX over the past year... no doubt all those post I've made in the past regarding those many mysterious days where DYAX was having 25-50% of its daily volume traded AH with no price movement was a sign of accumulation. Of course, their deeds were done at fixed prices (somehow) AH to keep from ramping the stock price during market hours as the volume during the day was simply not heavy enough to support the accumulation that was going on.

I'm projecting that the conclusion of Eli Lilly Phase III results on Ramucirumad will send DYAX to $5.50+ range in 2013. Double-digits by conclusion of 2015. Remember, it was just a few months ago that Eli Lilly was upgraded to BUY based on its Ramucirumad results thus far with GASTRIC cancer. What you must remember however, is that Eli Lilly actually has other phase III trials going on with Ramucirumad ... BREAST cancer trials, COLORECTAL cancer trials, LUNG cancer trials, and LIVER cancer trials.

DYAX will get royalties from ALL these. Plus, Eli Lilly is just ONE of MANY of DYAX partners. I'm waiting for the MS drug results in partnership with Biogen... DYAX already has Biogen's former Medical Research Director serving as their Chief Medical Officer.

I'm not saying anything I haven't already said before here. Been holding DYAX for over 18 months now. Growing rich slowly. Hardly trading at all. My largest holding STILL.
What would you like to do? Message: Endorse | Bookmark | Report AbuseUser hazeleye: Reward | Watch | IgnoreDYAX: Ignore

Msg Top | Msg List | < Prev | Next > | Post New | Reply | Privately | Search | Add DYAX | About Us | Agreement & Disclaimer | Privacy | Twitter
© 1999-, Inc.